1. Home
  2. PMAX vs VTAK Comparison

PMAX vs VTAK Comparison

Compare PMAX & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Max Limited

PMAX

Powell Max Limited

HOLD

Current Price

$2.79

Market Cap

4.5M

Sector

N/A

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.68

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMAX
VTAK
Founded
2019
2002
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.1M
IPO Year
2024
2018

Fundamental Metrics

Financial Performance
Metric
PMAX
VTAK
Price
$2.79
$1.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
52.6K
Earning Date
09-23-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,799,100.00
$730,000.00
Revenue This Year
N/A
$822.86
Revenue Next Year
N/A
$168.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
82.96
52 Week Low
$1.56
$1.49
52 Week High
$22.00
$15.68

Technical Indicators

Market Signals
Indicator
PMAX
VTAK
Relative Strength Index (RSI) 56.80 33.44
Support Level $2.17 $2.00
Resistance Level $2.94 $3.06
Average True Range (ATR) 0.22 0.24
MACD 0.01 -0.09
Stochastic Oscillator 60.00 0.00

Price Performance

Historical Comparison
PMAX
VTAK

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: